134 related articles for article (PubMed ID: 3863807)
1. Inflammatory characteristics of PAF-acether in the skin of experimental animals and man.
Archer CB; Page CP; Paul W; Morley J; MacDonald DM
Int J Tissue React; 1985; 7(5):363-5. PubMed ID: 3863807
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory characteristics of platelet activating factor (PAF-acether) in human skin.
Archer CB; Page CP; Paul W; Morley J; MacDonald DM
Br J Dermatol; 1984 Jan; 110(1):45-50. PubMed ID: 6581831
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous and pulmonary histopathological responses to platelet activating factor (Paf-acether) in the guinea-pig.
Dewar A; Archer CB; Paul W; Page CP; MacDonald DM; Morley J
J Pathol; 1984 Sep; 144(1):25-34. PubMed ID: 6481526
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory cell accumulation in response to intracutaneous Paf-acether: a mediator of acute and persistent inflammation?
Archer CB; Page CP; Paul W; Morley J; MacDonald DM
Br J Dermatol; 1985 Jul; 113 Suppl 28():133-5. PubMed ID: 4015978
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of inflammatory cells in response to intracutaneous platelet activating factor (Paf-acether) in man.
Archer CB; Page CP; Morley J; MacDonald DM
Br J Dermatol; 1985 Mar; 112(3):285-90. PubMed ID: 3978036
[TBL] [Abstract][Full Text] [Related]
6. Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin.
Sansom JE; Brooks J; Burton JL; Archer CB
Clin Exp Dermatol; 1996 Jan; 21(1):33-7. PubMed ID: 8689766
[TBL] [Abstract][Full Text] [Related]
7. Synergistic interaction between prostaglandins and PAF-acether in experimental animals and man.
Archer CB; Frohlich W; Page CW; Paul W; Morley J; MacDonald DM
Prostaglandins; 1984 Mar; 27(3):495-501. PubMed ID: 6203139
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory actions of platelet activating factor (Pafacether) in guinea-pig skin.
Morley J; Page CP; Paul W
Br J Pharmacol; 1983 Nov; 80(3):503-9. PubMed ID: 6685552
[TBL] [Abstract][Full Text] [Related]
9. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE.
Mencia-Huerta JM; Lewis RA; Razin E; Austen KF
J Immunol; 1983 Dec; 131(6):2958-64. PubMed ID: 6315819
[TBL] [Abstract][Full Text] [Related]
10. Effects of serum albumin, indomethacin and histamine H1-antagonists on Paf-acether-induced inflammatory responses in the skin of experimental animals and man.
Archer CB; MacDonald DM; Morley J; Page CP; Paul W; Sanjar S
Br J Pharmacol; 1985 May; 85(1):109-13. PubMed ID: 2862936
[TBL] [Abstract][Full Text] [Related]
11. PAF-acether-induced plasma exudation in rat skin is independent of platelets and neutrophils.
Pirotzky E; Page CP; Roubin R; Pfister A; Paul W; Bonnet J; Benveniste J
Microcirc Endothelium Lymphatics; 1984 Feb; 1(1):107-22. PubMed ID: 6546141
[TBL] [Abstract][Full Text] [Related]
12. Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988.
Issekutz AC; Szpejda M
Lab Invest; 1986 Mar; 54(3):275-81. PubMed ID: 3951199
[TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor: a possible mediator of the dual response to allergen?
Basran GS; Page CP; Paul W; Morley J
Clin Allergy; 1984 Jan; 14(1):75-9. PubMed ID: 6697475
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of PAF-acether induced weal and flare reaction in man by a specific PAF antagonist.
Guinot P; Braquet P; Duchier J; Cournot A
Prostaglandins; 1986 Jul; 32(1):160-3. PubMed ID: 3763944
[TBL] [Abstract][Full Text] [Related]
15. Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Paf-acether and acetyl-transferase activity in human leukocytes.
Jouvin-Marche E; Ninio E; Beaurain G; Tence M; Niaudet P; Benveniste J
J Immunol; 1984 Aug; 133(2):892-8. PubMed ID: 6736649
[TBL] [Abstract][Full Text] [Related]
16. Exercise- and allergen-induced asthma do not change the production of Paf-acether by neutrophils and platelets.
Lurie A; Dessanges JF; Delautier D; Coëffier E; Chignard M; Crémer GA; Benveniste J; Marsac J; Lockhart A
Bull Eur Physiopathol Respir; 1987; 23(4):347-51. PubMed ID: 3690021
[TBL] [Abstract][Full Text] [Related]
17. [Synthesis of paf-acether by E. coli K12].
Thomas Y; Denizot Y; Dassa E; Boullet C; Benveniste J
C R Acad Sci III; 1986; 303(17):699-702. PubMed ID: 3101984
[TBL] [Abstract][Full Text] [Related]
18. Age-dependent differential development of leukotactic and vasoactive responsiveness to acute inflammatory mediators.
Angle MJ; McManus LM; Pinckard RN
Lab Invest; 1986 Dec; 55(6):616-21. PubMed ID: 3465972
[TBL] [Abstract][Full Text] [Related]
19. Properties of PAF-acether appropriate to a mediator of the inflammatory aspects of asthma.
Page CP; Archer CB; Guerreiro D; Morley J
Int J Tissue React; 1985; 7(5):351-4. PubMed ID: 4055261
[TBL] [Abstract][Full Text] [Related]
20. Synergism between platelet-activating factor (PAF-acether) and prostaglandin E2 in man.
McGivern DV; Basran GS
Eur J Pharmacol; 1984 Jun; 102(1):183-5. PubMed ID: 6592097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
